Alcon Inc.
HealthcareNYSE:ALC · New York Stock Exchange
+$0.18 today
Vol 0.76M · Avg 1.93M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$10.6B of revenue converted into $815.3M of net income for the selected period. Gross margin is 54.9% and net margin is 7.7%, showing how much revenue survives after costs and taxes. EPS is $1.65, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.4B +4.9% | $9.9B +4.8% | $9.5B +8.5% | $8.7B +5.1% | $8.3B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $4.7B +5.8% | $4.4B +4.5% | $4.2B +6.0% | $4.0B +9.1% | $3.6B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $5.7B +4.2% | $5.5B +5.1% | $5.2B +10.5% | $4.7B +2.1% | $4.7B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 55.2% -0.4pp | 55.6% +0.1pp | 55.5% +1.0pp | 54.5% -1.6pp | 56.1% | 9.8% | 28.9% | 38.3% |
| Research & Development | $990.0M +13.0% | $876.0M +2.0% | $859.0M +22.4% | $702.0M -16.6% | $842.0M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $3.4B +6.1% | $3.3B +1.3% | $3.2B +4.6% | $3.1B -0.3% | $3.1B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $4.4B +7.0% | $4.1B -2.6% | $4.2B +3.2% | $4.1B +0.1% | $4.1B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $1.2B -3.0% | $1.2B +0.6% | $1.2B +5.3% | $1.2B -5.1% | $1.2B | $374.2M | $1.2B | $631.8M |
| EBITDA | $2.4B -12.1% | $2.7B +19.4% | $2.2B +26.2% | $1.8B +0.9% | $1.8B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 22.6% -4.4pp | 27.0% +3.3pp | 23.7% +3.3pp | 20.4% -0.9pp | 21.2% | 5.6% | 46.3% | 42.0% |
| Operating Income | $1.4B -3.8% | $1.4B +36.0% | $1.0B +54.6% | $672.0M +15.9% | $580.0M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 13.1% -1.2pp | 14.3% +3.3pp | 11.0% +3.3pp | 7.7% +0.7pp | 7.0% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 -100.0% | $81.5M +139.6% | $34.0M +105.7% | $16.5M +449.7% | $3.0M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 -100.0% | $186.2M -1.5% | $189.0M +36.6% | $138.4M +15.1% | $120.3M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$200.0M -27.4% | -$157.0M +24.2% | -$207.0M +1.0% | -$209.0M -29.0% | -$162.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $1.2B -7.6% | $1.3B +51.0% | $832.0M +79.7% | $463.0M +10.8% | $418.0M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 11.2% -1.5pp | 12.7% +3.9pp | 8.8% +3.5pp | 5.3% +0.3pp | 5.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $180.0M -24.4% | $238.0M +267.6% | -$142.0M -210.9% | $128.0M +204.8% | $42.0M | $1.3B | -$1.6B | $745.2M |
| Net Income | $980.0M -3.7% | $1.0B +4.5% | $974.0M +190.7% | $335.0M -10.9% | $376.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | 9.4% -0.8pp | 10.3% -0.0pp | 10.3% +6.5pp | 3.8% -0.7pp | 4.5% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $2 -3.4% | $2 +4.0% | $2 +191.2% | $1 -11.7% | $1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $2 -3.4% | $2 +4.6% | $2 +188.2% | $1 -10.5% | $1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $494.9M +0.1% | $494.4M +0.3% | $493.0M +0.3% | $491.4M +0.3% | $490.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $496.2M -0.3% | $497.5M +0.2% | $496.5M +0.4% | $494.4M +0.2% | $493.4M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Becton, Dickinson and Company
NYSE:BDX
$52.84B
Cardinal Health, Inc.
NYSE:CAH
$52.46B
Humana Inc.
NYSE:HUM
$45.39B
Agilent Technologies, Inc.
NYSE:A
$36.57B
IQVIA Holdings Inc.
NYSE:IQV
$29.88B
GE HealthCare Technologies Inc.
NASDAQ:GEHC
$29.52B
ResMed Inc.
NYSE:RMD
$28.07B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.26B
Mettler-Toledo International Inc.
NYSE:MTD
$22.83B
Insmed Incorporated
NASDAQ:INSM
$21.22B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does ALC generate?
Alcon Inc. (ALC) reported $10.40B of revenue in fiscal 2025.
Is ALC profitable?
Alcon Inc. (ALC) reported $980.00M of net income, with a net margin of 9.4%.
Explore More
Continue the stock analysis
Jump to another research area for this company.